Company / Revenue per Share
Altimmune, Inc. Revenue per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.00
FY2025
5-year range
-$0.00 / $0.22
FY2021-FY2025
Trend
-90.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 10 years, ranging from $-0.00 in FY2023 to $17.65 in FY2018.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -72.8%.
Improved from $-0.00 to $0.00 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -82.6%
- 5-Year CAGR
- -72.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 90.6% year-over-year.
- Peak revenue per share was recorded in FY2018.
- Lowest revenue per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -90.6% |
| FY2024 | $0.01 | +536.1% |
| FY2023 | -$0.00 | -101.3% |
| FY2022 | $0.11 | -51.2% |
| FY2021 | $0.22 | -41.8% |
| FY2020 | $0.38 | -66.7% |
| FY2019 | $1.14 | -93.6% |
| FY2018 | $17.65 | +3672.0% |
| FY2017 | $0.47 | +3.0% |
| FY2011 | $0.45 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026